THERAPY OF COUGHING SYNDROME IN RESPIRATORY INFECTIONS IN CHILDREN
https://doi.org/10.21518/2079-701X-2017-19-102-103
Abstract
About the Authors
V. K. KotlukovRussian Federation
PhD in medicine,
Moscow
T. V. Kazyukova
Russian Federation
MD, Prof.,
Moscow
N. V. Antipova
Russian Federation
Moscow
References
1. Исследование мнения провизоров и фармацевтов России. Pharma-Q, 2009.
2. Самсыгина Г.А. Противокашлевые препараты в педиатрии. Consilium Medicum. Педиатрия, Приложение, 2002: 13–16.
3. Ключников С.О. Препараты от кашля в амбулаторной практике педиатра. РМЖ, 2011, 3: 134–138.
4. Sih T, Clement PAR. Pediatric Nasal and Sinus Disorders. In: Lung Biology in Health and Disease. Taylor and Francis Group, USA, 2005, 199: 451.
5. Materazzi F, Capano P, D’Urso B, Visco A. Note terapeutiche sul butamirato citrato. Gazz. med. ital., 1984, 143(4): 229–232.
6. Santos A. and Nacpil N. Comparative clinical evaluation of the antitussive activity of butamirate citrate versus dextromethorphan. Manilla (Philippines): Lung Center of the Philippines. 1994.
Review
For citations:
Kotlukov VK, Kazyukova TV, Antipova NV. THERAPY OF COUGHING SYNDROME IN RESPIRATORY INFECTIONS IN CHILDREN. Meditsinskiy sovet = Medical Council. 2017;(19):102-103. (In Russ.) https://doi.org/10.21518/2079-701X-2017-19-102-103